Cargando…
Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes
OBJECTIVES: In myelodysplastic syndromes (MDS), neoplastic myeloblast (CD34+CD13+CD33+ cells) numbers often increase over time, leading to secondary acute myeloid leukemia (AML). In recent studies, blasts in some MDS patients have been found to express a megakaryocyte-lineage molecule, CD41, and suc...
Autores principales: | Ogata, Kiyoyuki, Mochimaru, Yuto, Sei, Kazuma, Kawahara, Naoya, Ogata, Mika, Yamamoto, Yumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10511088/ https://www.ncbi.nlm.nih.gov/pubmed/37729123 http://dx.doi.org/10.1371/journal.pone.0291662 |
Ejemplares similares
-
Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study
por: Brouwer, Nienke, et al.
Publicado: (2022) -
Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype
por: Koulmane Laxminarayana, Sindhura Lakshmi, et al.
Publicado: (2023) -
Coexistence of myelodysplastic syndrome and acute megakaryoblastic leukemia: An aggressive disease
por: Kasinathan, Ganesh, et al.
Publicado: (2021) -
A Jehovah's Witness with Acute Myeloid Leukemia Successfully Treated with an Epigenetic Drug, Azacitidine: A Clue for Development of Anti-AML Therapy Requiring Minimum Blood Transfusions
por: Yamamoto, Yumi, et al.
Publicado: (2014) -
Immunophenotypic changes of monocytes in myelodysplastic syndrome and clinical significance
por: Li, Lijuan, et al.
Publicado: (2022)